Polyneuropathy
Point-of-Care Conduction Device May Accurately Screen for Polyneuropathy in At-Risk Populations
May 29, 2018A point-of-care conduction device may provide accurate measurements of nerve amplitude potential and conduction velocity for the diagnosis of polyneuropathy in older patients.
Chronic Inflammatory Demyelinating Polyneuropathy: Privigen Gains FDA Approval
October 10, 2017Privigen is stabilized with proline, which has been shown to reduce IgG aggregation and dimer formation.
Long-Term Opioid Therapy Linked to Adverse Effects in Polyneuropathy
August 24, 2017Long-term treatment with opioids is associated with more adverse outcomes in patients with polyneuropathy, including depression, overdose, and opioid dependence.
Long-Term Opioids Associated With Worse Functional Status, Adverse Events in Polyneuropathy
June 02, 2017Polyneuropathy may increase the likelihood of patients receiving long-term opioid therapy.
Classification of Peripheral Neuropathic Pain Based on Sensory Profiles
February 17, 2017Researchers identified 3 subgroups of patients with peripheral neuropathic pain, based on sensory signs and symptoms.
Risk Factors for Polyneuropathy
November 09, 2016Diabetes, prediabetes, and obesity may be metabolic drivers of polyneuropathy.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Patterns of Non-Medical Prescription Opioid Use in Adolescents
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds
